Achieve Life Sciences, Inc. (ACHV) stock
ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as QUIT
$6.72+0.34 (+5.33%)
Close on Nov 6, 2026Market cap $691.51MP/E –Yield –
Achieve Life Sciences shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Achieve Life Sciences's shares outstanding was 94M at Jun 30, 2026. For fiscal 2025 it was 44M, up 35.9% from the year before. Over ten years it grew 114.4% a year on average. The highest annual figure on record is 44M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 44M | +35.9% |
| FY2024 | Dec 31, 2024 | 32M | +61.8% |
| FY2023 | Dec 31, 2023 | 20M | +87.2% |
| FY2022 | Dec 31, 2022 | 11M | +30.5% |
| FY2021 | Dec 31, 2021 | 8M | +198.6% |
| FY2020 | Dec 31, 2020 | 3M | +559.4% |
| FY2019 | Dec 31, 2019 | 0M | +134.9% |
| FY2018 | Dec 31, 2018 | 0M | -63.4% |
| FY2017 | Dec 31, 2017 | 0M | +22483.2% |
| FY2016 | Dec 31, 2016 | 0M | -90.0% |
| FY2015 | Dec 31, 2015 | 0M | +65.4% |
| FY2014 | Dec 31, 2014 | 0M | +23.3% |
| FY2013 | Dec 31, 2013 | 0M | +8.6% |
| FY2012 | Dec 31, 2012 | 0M | +39.0% |
| FY2011 | Dec 31, 2011 | 0M | +38.4% |
| FY2010 | Dec 31, 2010 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 94M | +169.6% |
| Q1 FY2026 | Mar 31, 2026 | 53M | +53.9% |
| Q4 FY2025 | Dec 31, 2025 | 54M | +55.8% |
| Q3 FY2025 | Sep 30, 2025 | 51M | +48.5% |
| Q2 FY2025 | Jun 30, 2025 | 35M | +1.1% |
| Q1 FY2025 | Mar 31, 2025 | 35M | +38.5% |
| Q4 FY2024 | Dec 31, 2024 | 35M | +63.0% |
| Q3 FY2024 | Sep 30, 2024 | 34M | +62.6% |
| Q2 FY2024 | Jun 30, 2024 | 34M | +80.2% |
| Q1 FY2024 | Mar 31, 2024 | 25M | +39.8% |
| Q4 FY2023 | Dec 31, 2023 | 21M | +56.1% |
| Q3 FY2023 | Sep 30, 2023 | 21M | +117.9% |
| Q2 FY2023 | Jun 30, 2023 | 19M | +97.4% |
| Q1 FY2023 | Mar 31, 2023 | 18M | +89.4% |
| Q4 FY2022 | Dec 31, 2022 | 14M | +43.3% |
| Q3 FY2022 | Sep 30, 2022 | 10M | +2.6% |
| Q2 FY2022 | Jun 30, 2022 | 10M | +30.5% |
| Q1 FY2022 | Mar 31, 2022 | 9M | +54.3% |
| Q4 FY2021 | Dec 31, 2021 | 9M | +121.0% |
| Q3 FY2021 | Sep 30, 2021 | 9M | +187.4% |
| Q2 FY2021 | Jun 30, 2021 | 7M | +323.8% |
| Q1 FY2021 | Mar 31, 2021 | 6M | +296.4% |
| Q4 FY2020 | Dec 31, 2020 | 4M | +681.7% |
| Q3 FY2020 | Sep 30, 2020 | 3M | +712.1% |
| Q2 FY2020 | Jun 30, 2020 | 2M | +385.1% |
| Q1 FY2020 | Mar 31, 2020 | 2M | -77.0% |
| Q4 FY2019 | Dec 31, 2019 | 1M | -87.9% |
| Q3 FY2019 | Sep 30, 2019 | 0M | -73.5% |
| Q2 FY2019 | Jun 30, 2019 | 0M | -71.1% |
| Q1 FY2019 | Mar 31, 2019 | 7M | +830.2% |
| Q3 FY2018 | Sep 30, 2018 | 5M | +213463.0% |
| Q2 FY2018 | Jun 30, 2018 | 2M | +7104.6% |
| Q1 FY2018 | Mar 31, 2018 | 1M | +5755.6% |
| Q3 FY2017 | Sep 30, 2017 | 1M | – |
| Q2 FY2017 | Jun 30, 2017 | 0M | – |
| Q1 FY2017 | Mar 31, 2017 | 0M | – |
| Q3 FY2016 | Sep 30, 2016 | 0M | – |
See a number that looks wrong?